Active Stocks
Thu Feb 29 2024 15:49:54
  1. Kotak Mahindra Bank share price
  2. 1,690.80 0.43%
  1. Axis Bank share price
  2. 1,075.70 0.10%
  1. Tata Steel share price
  2. 140.90 0.11%
  1. Power Grid Corporation Of India share price
  2. 282.55 1.07%
  1. ITC share price
  2. 406.50 -0.51%
Business News/ Companies / News/  World Bank arm to invest $47.5 million in Granules India
BackBack

World Bank arm to invest $47.5 million in Granules India

Granules is building a bulk drug manufacturing facility in Vishakhapatnam, expanding existing capacities and investing in R&D, with a total investment of $84 million needed

This is the fourth investment made by IFC in Granules India after it first made the debt and equity investment in 2007. IFC exited the equity investment in 2014.Premium
This is the fourth investment made by IFC in Granules India after it first made the debt and equity investment in 2007. IFC exited the equity investment in 2014.

New York: International Finance Corp. (IFC), the private-sector lending arm of the World Bank, on Monday said it will provide debt of $47.5 million (Rs318 crore) to drug maker Granules India Ltd to help finance its investment plans.

Granules India is building a bulk drug manufacturing facility in Vishakhapatnam, expanding its existing capacities and investing in research and development to make products with higher value addition. The total investment required is estimated at about $84 million, with debt of $68.5 million, including IFC’s contribution. The remaining will be met through equity and internal accruals, IFC said in a disclosure.

Granules is engaged in making bulk drugs, formulation intermediates and finished dosages of a variety of drugs. Apart from India, it sells its products in the US, Europe and Latin America.

It has factories near Hyderabad and Vishakhapatnam, along with an R&D and manufacturing facility in Virginia, US. Through its joint ventures, Granules also has one plant in China and another plant in Vishakhapatnam.

This is the fourth investment made by IFC in Granules India after it first made the debt and equity investment in 2007. IFC exited the equity investment in 2014.

Subsequently in 2009, IFC provided a Cleaner Production Lending Facility (CPLF) loan and a debt investment in 2011 for its Granules India capacity expansion of its Gagillapur facility.

In the pharmaceutical sector, IFC has invested in Glenmark Pharmaceuticals, Jubilant Pharma and Vivimed Labs, among others.

In July 2016, Granules India agreed to acquire 12.5% equity stake in US-based drug maker USpharma Inc. for an undisclosed amount through its wholly-owned subsidiary Granules Pharmaceuticals Inc.

IFC has an active direct private equity-style investment practice in India. It also lends to firms and has an active limited partner, or LP, portfolio in India where it backs PE and VC funds.

Most recently, it invested $125 million in Hero Future Energies, the renewable energy arm of the Hero Group, for an undisclosed equity stake. The World Bank arm also committed to invest $20 million in IDG Ventures India’s third country-focused fund which has a target corpus of $200 million.

In September last year, it announced to invest up to $40 million in Bengaluru-based microfinance firm Ujjivan Financial Services Ltd in the form of debt.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Check all the latest action on Budget 2024 here. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 20 Feb 2017, 11:51 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App